SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Avian ("Bird") Flu Stocks
NNVC 1.660-2.4%Oct 31 9:30 AM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: manny t who wrote (189)12/23/2005 9:26:58 AM
From: Galirayo   of 428
 
AP
Novavax Gets $8 Million Drug Payment
Friday December 23, 7:39 am ET
Novavax Receives $8 Million Estrasorb Payment From Esprit Pharma

MALVERN, Pa. (AP) -- Biotech company Novavax Inc. said Friday that it received its second cash payment from Esprit Pharma Inc. for North American rights to Estrasorb topical estrogen therapy.
Novavax received a cash payment of $8 million from Esprit, bringing total payments under the agreement to $10 million. Under the agreement, which was signed in October, Novavax will receive another payment of $2.5 million at the agreement's one-year anniversary.

Shares of Novavax were up 2.3 percent in premarket trading at $4.06, compared with the Thursday close of $3.97 on the Nasdaq.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext